TrademarkDir
THERAPURE BIOLOGICS
DEAD

Serial Number

86655356

Owner

THERAPURE BIOPHARMA INC.

Attorney

Christoher J. Schulte

Filing Date

Jun 8, 2015

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

THERAPURE BIOLOGICS Trademark

Serial Number: 86655356

THERAPURE BIOLOGICS is a trademark filed by THERAPURE BIOPHARMA INC. on June 8, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). The application is currently no longer active.

Owner Contact Info

THERAPURE BIOPHARMA INC. (9 trademarks)

2585 MEADOWPINE BLVD
MISSISSAUGA, ONTARIO L5N8H9 , CA

Entity Type: 03

Trademark Details

Filing Date

June 8, 2015

Registration Date

Not Registered

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 1, 2020 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 1, 2020 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 13, 2019 GNFN
FINAL REFUSAL E-MAILED
Sep 13, 2019 GNFR
FINAL REFUSAL WRITTEN
Sep 13, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 4, 2019 CRFA
ASSIGNED TO LIE
Sep 3, 2019 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 22, 2019 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 4, 2019 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 4, 2019 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 4, 2019 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 4, 2019 RCCK
ASSIGNED TO LIE
Feb 28, 2019 ALIE
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 8, 2018 RCSC
ASSIGNED TO LIE
Aug 7, 2018 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 6, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 6, 2018 GNSL
SUSPENSION LETTER WRITTEN
Feb 6, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2018 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 31, 2018 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 23, 2017 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 23, 2017 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 23, 2017 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 22, 2017 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 16, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 16, 2017 GNSL
SUSPENSION LETTER WRITTEN
Feb 16, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 16, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 16, 2017 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 9, 2017 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 12, 2016 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 12, 2016 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 12, 2016 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 11, 2016 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 5, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 5, 2016 GNSL
SUSPENSION LETTER WRITTEN
Feb 5, 2016 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 27, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 27, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 24, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 4, 2015 GNRN
NON-FINAL ACTION E-MAILED
Aug 4, 2015 GNRT
NON-FINAL ACTION WRITTEN
Aug 4, 2015 CNRT
ASSIGNED TO EXAMINER
Aug 3, 2015 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jun 30, 2015 AMPX
ASSIGNED TO LIE
Jun 25, 2015 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 17, 2015 PARI
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 12, 2015 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 11, 2015 NWOS
NEW APPLICATION ENTERED
Jun 11, 2015 NWAP

Related Trademarks

More from this Owner

THERAPURE BIOLOGICS

THERAPURE BIOLOGICS

DAKANSUMIN

DAKANSUMIN

DAKANSUMIN

DAKANSUMIN

DAKANSUMIN

DAKANSUMIN

PLASMACAP

PLASMACAP

PLASMACAP

PLASMACAP